1. A Cancer Chemo-Prevention Compromise
... -prevention trials have confirmed the obstacles of weighing risks and benefits associated with chemo preventive agents (Bernhard 1). Now knowing the low baseline risk of breast cancer among trial participants, one can feel that IRBs should truly focus more on the magnitude of change in disease rates among the population when calculating prospective benefits and risks connected ... trial compared raloxifene to tomoxifen to investigate whether an equivalent benefit could be reached with fewer grim side effects. Both remedies were found to diminish the threat of emergent intrusive breast c...
- Word Count: 1354
- Approx Pages: 5
- Has Bibliography
- Grade Level: Graduate